These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 5135408)

  • 1. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
    Aubry F; Lapierre YL; Noël C; Davignon J
    Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives.
    Patterson D; Slack J
    Lancet; 1972 Feb; 1(7747):393-9. PubMed ID: 4110639
    [No Abstract]   [Full Text] [Related]  

  • 4. Familial hyper-pre-betalipoproteinemia with observations on the metabolism of endogenous particles.
    Rose HG
    J Lab Clin Med; 1970 Jul; 76(1):92-102. PubMed ID: 5425367
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary eruptive xanthoma. Type V hyperlipoproteinemia.
    Schreiber MM; Shapiro SI
    Arch Dermatol; 1969 Nov; 100(5):601-3. PubMed ID: 5350416
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A
    Postgrad Med J; 1975; 51(8):66-71. PubMed ID: 768950
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hyperlipoproteinemia in out-patients. Occurrence, type distribution and correlation to clinical findings].
    Wollenweber J; Christl HL; Schlierf C; Wohlenberg H
    Dtsch Med Wochenschr; 1973 Mar; 98(10):463-9. PubMed ID: 4691568
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential familial hypercholesterolemia with xanthomatosis.
    Hould F; Leclerc R; Marcoux J
    Pediatrics; 1969 Mar; 43(3):455-9. PubMed ID: 5775198
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperlipoproteinaemia in gout.
    Bluestone R; Lewis B; Mervart I
    Ann Rheum Dis; 1971 Mar; 30(2):134-7. PubMed ID: 5569433
    [No Abstract]   [Full Text] [Related]  

  • 11. Bilateral parotid gland enlargement and hyperlipoproteinemia.
    Kaltreider HB; Talal N
    JAMA; 1969 Dec; 210(11):2067-70. PubMed ID: 5395209
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver scan in hyperlipoproteinemia.
    Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
    JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
    [No Abstract]   [Full Text] [Related]  

  • 13. Musculoskeletal disorders associated with type-IV hyperlipoproteinaemia.
    Goldman JA; Glueck CJ; Abrams NR; Steiner P; Herman JH
    Lancet; 1972 Sep; 2(7775):449-52. PubMed ID: 4115343
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hyperlipoproteinemia type 3.
    Fleischmajer R
    Arch Dermatol; 1969 Oct; 100(4):401-6. PubMed ID: 4311549
    [No Abstract]   [Full Text] [Related]  

  • 15. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 16. Human plasma fatty acid composition: the features of hyperlipoproteinemia and the influence of -linolenate and clofibrate.
    Takayasu K; Tada T; Okada F; Yoshikawa I
    Jpn Circ J; 1971 Sep; 35(9):1059-69. PubMed ID: 5172104
    [No Abstract]   [Full Text] [Related]  

  • 17. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
    Morganroth J; Levy RI; Fredrickson DS
    Ann Intern Med; 1975 Feb; 82(2):158-74. PubMed ID: 163608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 4 hyperlipoproteinemia: one theory of atherogenesis.
    Zelis R; Salel AF
    Chest; 1973 Oct; 64(4):486-90. PubMed ID: 4355275
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prevalence of lipid metabolism disorders in rheumatological diseases].
    Frank O; Tidl G
    Wien Med Wochenschr; 1974 Sep; 124(37):527-30. PubMed ID: 4547104
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
    Borrie P; Slack J
    Br J Dermatol; 1974 Mar; 90(3):245-53. PubMed ID: 4823081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.